The summit, co-hosted by the Canadian Pharmacists Association (CPhA) and the American Pharmacists Association (APhA) alongside the International Pharmaceutical Federation (FIP), sought to move pharmacist-led care from isolated pilot programs to standard practice. Participants analyzed how varying reimbursement models and educational standards currently dictate the efficacy of patient care across different national borders.

Glen Doucet, CEO of the CPhA, emphasized that integrating pharmacists is a strategic necessity for health systems facing mounting patient volume. The objective is to utilize existing clinical capacity to bolster care quality rather than simply expanding professional scope in name only. Michael Hogue, CEO of the APhA, echoed this sentiment, noting that success relies on creating environments where teams have the resources to operate at their full potential. FIP CEO Catherine Duggan underscored the value of cross-border data, suggesting that while local realities vary, the fundamental challenges of workforce development and system design remain universal. The findings from this dialogue will be compiled into a joint report designed to guide policy development in North America and beyond, serving as a roadmap ahead of the 84th FIP World Congress of Pharmacy and Pharmaceutical Sciences.